Details for Patent: 7,344,702
✉ Email this page to a colleague
Which drugs does patent 7,344,702 protect, and when does it expire?
Patent 7,344,702 protects FLYRCADO and is included in one NDA.
This patent has forty-one patent family members in twenty countries.
Drugs Protected by US Patent 7,344,702
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Hlthcare | FLYRCADO | flurpiridaz f-18 | SOLUTION;INTRAVENOUS | 215168-001 | Sep 27, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,344,702
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2005214898 | ⤷ Subscribe | |||
Brazil | PI0507684 | ⤷ Subscribe | |||
Canada | 2556213 | ⤷ Subscribe | |||
Canada | 2828128 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |